Cargando…

Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies

Noncolorectal gastrointestinal (GI) malignancies are among the most frequently diagnosed cancers. Despite the undeniable progress in systemic treatments in recent decades, further improvements using cytotoxic chemotherapy seem unlikely. In this setting, recent discoveries regarding the mechanism und...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jesus, Victor Hugo Fonseca, Felismino, Tiago Cordeiro, de Barros e Silva, Milton José, de Souza e Silva, Virgílio, Riechelmann, Rachel P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173942/ https://www.ncbi.nlm.nih.gov/pubmed/30365605 http://dx.doi.org/10.6061/clinics/2018/e510s

Ejemplares similares

Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome
por: Elze, Lisa, et al.
Publicado: (2023)

Correction to: Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome
Publicado: (2023)

Clinical factors related to severe enterocolitis after adjuvant CAPOX for colorectal cancer: a retrospective analysis
por: Felismino, Tiago Cordeiro, et al.
Publicado: (2020)

Screening Colonoscopy Findings Are Associated With Noncolorectal Cancer Mortality
por: Sullivan, Brian A., et al.
Publicado: (2022)

Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases
por: van Iersel, Liselot B. J., et al.
Publicado: (2008)

Evaluation of prognostic factors in patients undergoing first-line chemotherapy for advanced biliary tract cancer: a retrospective analysis from a South American cancer centre
por: Felismino, Tiago Cordeiro, et al.
Publicado: (2022)

Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist’s Perspective
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2023)

Is there a role for rechallenge and reintroduction of anti-EGFR plus chemotherapy in later lines of therapy for metastatic colorectal carcinoma? A retrospective analysis
por: Karani, Amanda, et al.
Publicado: (2020)

HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors
por: Barros, Milton J., et al.
Publicado: (2023)

Is microwave ablation therapy as effective as colorectal liver metastases in noncolorectal liver metastases?
por: DANIŞAN, Gürkan, et al.
Publicado: (2022)

Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2021)

Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayesian network meta-analysis
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2021)

Prognostic Factors Affecting Long-Term Survival after Resection for Noncolorectal, Nonneuroendocrine, and Nonsarcoma Liver Metastases
por: Uggeri, Fabio, et al.
Publicado: (2017)

Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis
por: Carvalho de Brito, Angelo Borsarelli, et al.
Publicado: (2023)

The prognostic influence of tumour budding in Western patients with stage II colorectal cancer
por: Canguçu, Augusto Leite, et al.
Publicado: (2020)

Current Molecular Profile of Gastrointestinal Stromal Tumors and Systemic Therapeutic Implications
por: Mathias-Machado, Maria Cecilia, et al.
Publicado: (2022)

Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies
por: Dillon, Alexander B., et al.
Publicado: (2015)

Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2018)

Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
por: Myint, Zin W., et al.
Publicado: (2017)

Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors
por: Li, Qingbo, et al.
Publicado: (2022)

Harnessing the abscopal effect for gastrointestinal malignancies in the era of immunotherapy
por: Hino, Christopher, et al.
Publicado: (2023)

Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies
por: An, Junyi, et al.
Publicado: (2023)

Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies
por: Zhu, Haipeng, et al.
Publicado: (2021)

Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges
por: Rocha, Lucila Soares da Silva, et al.
Publicado: (2018)

Current Status and Perspective of Immunotherapy in Gastrointestinal Cancers
por: Kim, Jung Hoon, et al.
Publicado: (2016)

Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play
por: Donlon, Noel E., et al.
Publicado: (2021)

Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer
por: Silva, Virgílio Souza e, et al.
Publicado: (2021)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Health resource utilisation by patients with neuroendocrine tumours with or without carcinoid heart disease: a multinational study
por: Tanaka, Hugo, et al.
Publicado: (2020)

Immunotherapy in Gastrointestinal Cancers
por: Procaccio, Letizia, et al.
Publicado: (2017)

Immunotherapy – new perspective in lung cancer
por: Pinheiro, Fillipe Dantas, et al.
Publicado: (2020)

Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
por: Lu, Zhihao, et al.
Publicado: (2020)

Body weight concerns: Cross-national study and identification of factors related to eating disorders
por: da Silva, Wanderson Roberto, et al.
Publicado: (2017)

Disparities in access to health care system as determinant of survival for patients with pancreatic cancer in the State of São Paulo, Brazil
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2021)

Clinical outcomes of patients with pancreatic tumors discussed in Tumor Board
por: SILVA, JULIANA RIBEIRO, et al.
Publicado: (2022)

Network analysis for science and technology management: Evidence from tuberculosis research in Fiocruz, Brazil
por: Fonseca, Bruna de Paula Fonseca e, et al.
Publicado: (2017)

Immunotherapy in glioblastoma treatment: Current state and future prospects
por: Rocha Pinheiro, Samuel Luca, et al.
Publicado: (2023)

Immunotherapy for malignant glioma
por: Suryadevara, Carter M., et al.
Publicado: (2015)

Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy
por: Hazama, Shoichi, et al.
Publicado: (2018)

γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
por: Barros, Mateus de Souza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j2i478honp25m683dqj8dllbil